Go back
New Study to Assess the Efficacy of Ivermectin Against COVID-19
Barcelona, 14 May 2020
- Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the ”la Caixa” Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19.
- The aim of the study, carried out in collaboration with Idifarma, is to determine whether administration of ivermectin is associated with a shorter viral clearance time.
- “Ivermectin has been shown to have an antiviral effect against other single-chain RNA viruses, including dengue and yellow fever, and it has successfully inhibited the replication of those viruses in vitro,” explained Carlos Chaccour, a specialist affiliated with Clínica Universidad de Navarra and ISGlobal and principal investigator for the new study.
Related news
Support to three innovative biomedical projects to help them transfer from the lab to the market
CaixaResearch Consolidate call for proposals resulted in the selection of three promising projects. Each will receive funding of 300,000 euros to help their innovations reach the market and society as a whole.
More than 23 million euros to 33 new health research projects in Spain and Portugal
The fifth 2022 CaixaResearch Call for Proposals in Health Research will provide funding for 33 new cutting-edge biomedical research projects in the two countries, with grants of up to one million euros per project.
The CaixaResearch Institute will be Spain’s first research centre specialising in immunology
”la Caixa” Foundation presents the scientific project of its future research center, focused on the study of the processes of the immune system in its interaction with the most prevalent conditions.
Mediterranean diet or mindfulness during pregnancy reduces the risk of a low birth weight baby
Researchers from BCNatal with the support of the ”la Caixa” Foundation has demonstrated for the first time a reduction of low birth weight babies up to 29% and 36%.
One Health: the holistic approach needed to tackle future pandemics
”la Caixa” Foundation and Biocat bring together the main experts in global health in a conference to discuss what they learned during Covid-19 and how to deal with upcoming pandemics.
The new ”la Caixa” Foundation - BIST Chemical Biology Programme launches a hub in Barcelona for the design of new drugs
The initiative aims to attract talent from the field of chemical biology, and to create an ecosystem that fosters research excellence in improving health.
